| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:996.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Childrens Hospital of Philadelphia (T.M.H., G.W., T.L.S.), Philadelphia, Pa; Medical University of South Carolina (A.M.A.), Charleston, SC; University of Michigan Hospital (T.J.K.), Ann Arbor, Mich; Childrens Hospital Medical Center (D.P.N.), Cincinnati, Ohio; Texas Childrens Hospital (A.C.C.), Houston, Tex; Emory University School of Medicine (J.M.B.), Atlanta, Ga; Sanofi-Synthelabo Inc (A.A., J.F.K.) New York, NY; Covance Periapproval Services Inc (R.K.), Radnor, Pa; and Boston Childrens Hospital (D.L.W.), Boston, Mass.
Correspondence to Gil Wernovsky, MD, Division of Cardiology, The Childrens Hospital of Philadelphia, 34th and Civic Center Blvd, Philadelphia, PA 19104. E-mail wernovsky{at}email.chop.edu
Background Low cardiac output syndrome (LCOS), affecting up to 25% of neonates and young children after cardiac surgery, contributes to postoperative morbidity and mortality. This study evaluated the efficacy and safety of prophylactic milrinone in pediatric patients at high risk for developing LCOS.
Methods and Results The study was a double-blind, placebo-controlled trial with 3 parallel groups (low dose, 25-µg/kg bolus over 60 minutes followed by a 0.25-µg/kg per min infusion for 35 hours; high dose, 75-µg/kg bolus followed by a 0.75-µg/kg per min infusion for 35 hours; or placebo). The composite end point of death or the development of LCOS was evaluated at 36 hours and up to 30 days after randomization. Among 238 treated patients, 25.9%, 17.5%, and 11.7% in the placebo, low-dose milrinone, and high-dose milrinone groups, respectively, developed LCOS in the first 36 hours after surgery. High-dose milrinone significantly reduced the risk the development of LCOS compared with placebo, with a relative risk reduction of 55% (P=0.023) in 238 treated patients and 64% (P=0.007) in 227 patients without major protocol violations. There were 2 deaths, both after infusion of study drug. The use of high-dose milrinone reduced the risk of the LCOS through the final visit by 48% (P=0.049).
Conclusions The use of high-dose milrinone after pediatric congenital heart surgery reduces the risk of LCOS.
Key Words: cardiac output heart defects, congenital pediatrics mortality
This article has been cited by other articles:
![]() |
L. Shekerdemian Perioperative manipulation of the circulation in children with congenital heart disease Heart, August 1, 2009; 95(15): 1286 - 1296. [Full Text] [PDF] |
||||
![]() |
J. R. Egan, T. L. Butler, A. D. Cole, S. Abraham, J. S. Murala, D. Baines, N. Street, L. Thompson, O. Biecker, J. Dittmer, et al. Myocardial membrane injury in pediatric cardiac surgery: An animal model. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1154 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Li, R. Chen, R. Huang, and W. Luo Clinical benefit of cardiac ischemic postconditioning in corrections of tetralogy of Fallot Interactive CardioVascular and Thoracic Surgery, January 1, 2009; 8(1): 17 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. D. Durandy, M. Younes, and B. Mahut Pediatric Warm Open Heart Surgery and Prolonged Cross-Clamp Time Ann. Thorac. Surg., December 1, 2008; 86(6): 1941 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Haas and C. K. Camphausen Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1215 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Egan, T. L. Butler, A. D. Cole, A. Aharonyan, D. Baines, N. Street, M. Navaratnam, O. Biecker, C. Zazulak, C. G. Au, et al. Myocardial ischemia is more important than the effects of cardiopulmonary bypass on myocardial water handling and postoperative dysfunction: A pediatric animal model. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1265 - 1273.e2. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Pasquali, M. Hall, A. D. Slonim, K. J. Jenkins, B. S. Marino, M. S. Cohen, and S. S. Shah Off-Label Use of Cardiovascular Medications in Children Hospitalized With Congenital and Acquired Heart Disease Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 74 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Topjian, R. A. Berg, and V. M. Nadkarni Pediatric Cardiopulmonary Resuscitation: Advances in Science, Techniques, and Outcomes Pediatrics, November 1, 2008; 122(5): 1086 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J.C. Mittnacht, M. Thanjan, S. Srivastava, U. Joashi, C. Bodian, S. Hossain, N. Kin, I. Hollinger, and K. Nguyen Extubation in the operating room after congenital heart surgery in children J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 88 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Hsu, P. E. Oishi, R. L. Keller, O. Chikovani, T. R. Karl, A. Azakie, I. Adatia, and J. R. Fineman Perioperative B-type natriuretic peptide levels predict outcome after bidirectional cavopulmonary anastomosis and total cavopulmonary connection. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 746 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Uhl Viral Myocarditis in Children Crit. Care Nurse, February 1, 2008; 28(1): 42 - 63. [Full Text] [PDF] |
||||
![]() |
G. Wernovsky Improving neurologic and quality-of-life outcomes in children with congenital heart disease: Past, present, and future J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 240 - 242. [Full Text] [PDF] |
||||
![]() |
N. Oka, L. Wang, W. Mi, W. Zhu, O. Honjo, and C. A. Caldarone Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 123 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Hsu, R. L. Keller, O. Chikovani, H. Cheng, S. A. Hollander, T. R. Karl, A. Azakie, I. Adatia, P. Oishi, and J. R. Fineman B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery. J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 939 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cannesson, C. Bionda, B. Gostoli, O. Raisky, S. di Filippo, D. Bompard, C. Vedrinne, R. Rousson, J. Ninet, J. Neidecker, et al. Time Course and Prognostic Value of Plasma B-type Natriuretic Peptide Concentration in Neonates Undergoing the Arterial Switch Operation Anesth. Analg., May 1, 2007; 104(5): 1059 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Paradisis, X. Jiang, A. J McLachlan, N. Evans, M. Kluckow, and D. Osborn Population pharmacokinetics and dosing regimen design of milrinone in preterm infants Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2007; 92(3): F204 - F209. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Durandy and S. Hulin Intermittent warm blood cardioplegia in the surgical treatment of congenital heart disease: Clinical experience with 1400 cases J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 241 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Denault, Y. Lamarche, P. Couture, F. Haddad, J. Lambert, J.-C. Tardif, and L. P. Perrault Inhaled milrinone: a new alternative in cardiac surgery? Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 346 - 360. [Abstract] [PDF] |
||||
![]() |
R K Kharbanda, J Li, I E Konstantinov, M M H Cheung, P A White, H Frndova, J Stokoe, P Cox, M Vogel, G Van Arsdell, et al. Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study Heart, October 1, 2006; 92(10): 1506 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rosenthal and D. Bernstein Pediatric Mechanical Circulatory Support: Challenges and Opportunities Circulation, May 16, 2006; 113(19): 2266 - 2268. [Full Text] [PDF] |
||||
![]() |
J. R. Egan, A. J. B. Clarke, S. Williams, A. D. Cole, J. Ayer, S. Jacobe, R. B. Chard, and D. S. Winlaw Levosimendan for Low Cardiac Output: A Pediatric Experience J Intensive Care Med, May 1, 2006; 21(3): 183 - 187. [Abstract] [PDF] |
||||
![]() |
L. Wang, C. Kinnear, J. M. Hammel, W. Zhu, Z. Hua, W. Mi, and C. A. Caldarone Preservation of Mitochondrial Structure and Function After Cardioplegic Arrest in the Neonate Using a Selective Mitochondrial K(ATP) Channel Opener. Ann. Thorac. Surg., May 1, 2006; 81(5): 1817 - 1823. [Abstract] [Full Text] [PDF] |
||||
![]() |
The International Liaison Committee on Resuscitati The International Liaison Committee on Resuscitation (ILCOR) Consensus on Science With Treatment Recommendations for Pediatric and Neonatal Patients: Pediatric Basic and Advanced Life Support Pediatrics, May 1, 2006; 117(5): e955 - e977. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Zuppa, S. C. Nicolson, P. C. Adamson, G. Wernovsky, J. T. Mondick, N. Burnham, T. M. Hoffman, J. W. Gaynor, L. A. Davis, W. J. Greeley, et al. Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction. Anesth. Analg., April 1, 2006; 102(4): 1062 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
Intracardiac temperature monitoring in infants after cardiac surgery. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 614 - 620. |
||||
![]() |
Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 632 - 638. |
||||
![]() |
M Hatherill, S Salie, Z Waggie, J Lawrenson, J Hewitson, L Reynolds, and A Argent Hyperchloraemic metabolic acidosis following open cardiac surgery Arch. Dis. Child., December 1, 2005; 90(12): 1288 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
Part 6: Pediatric Basic and Advanced Life Support Circulation, November 29, 2005; 112(22_suppl): III-73 - III-90. [Full Text] [PDF] |
||||
![]() |
M. Onomoto, I. Tsuneyoshi, A. Yonetani, S. Suehiro, K. Matsumoto, R. Sakata, and Y. Kanmura Differential Pharmacologic Sensitivities of Phosphodiesterase-3 Inhibitors Among Human Isolated Gastroepiploic, Internal Mammary, and Radial Arteries Anesth. Analg., October 1, 2005; 101(4): 950 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Mackie, K. L. Booth, J. W. Newburger, K. Gauvreau, S. A. Huang, P. C. Laussen, J. A. DiNardo, P. J. del Nido, J. E. Mayer Jr, R. A. Jonas, et al. A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 810 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Riphagen, M. McDougall, S. M. Tibby, N. Alphonso, D. Anderson, C. Austin, A. Durward, and I. A. Murdoch "Early" Delayed Sternal Closure Following Pediatric Cardiac Surgery Ann. Thorac. Surg., August 1, 2005; 80(2): 678 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
U Theilen and L Shekerdemian The intensive care of infants with hypoplastic left heart syndrome Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2005; 90(2): F97 - F102. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chaudhari, J. Sturman, J. O'Sullivan, J. Smith, N. Wrightson, G. Parry, D. Bolton, S. Haynes, L. Hamilton, and A. Hasan Rescue cardiac transplantation for early failure of the Fontan-type circulation in children J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 416 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Caldarone, E. W. Barner, L. Wang, M. Karimi, C. E. Mascio, J. M. Hammel, J. L. Segar, C. Du, and T. D. Scholz Apoptosis-related mitochondrial dysfunction in the early postoperative neonatal lamb heart Ann. Thorac. Surg., September 1, 2004; 78(3): 948 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Graham Jr The year in congenital heart disease J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2132 - 2141. [Full Text] [PDF] |
||||
![]() |
R. H. Jones The year in cardiovascular surgery J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1706 - 1714. [Full Text] [PDF] |
||||
![]() |
C. L Cua, T. M Hoffman, R. Taeed, S. Weinstein, D. Gomez, V. F Olshove, and J. M Craenen Cerebral saturations trend with mixed venous saturations in patients undergoing extracorporeal life support Perfusion, May 1, 2004; 19(3): 171 - 176. [Abstract] [PDF] |
||||
![]() |
A. Azakie, D. Martinez, A. Sapru, J. Fineman, D. Teitel, and T. R. Karl Impact of right ventricle to pulmonary artery conduit on outcome of the modified norwood procedure Ann. Thorac. Surg., May 1, 2004; 77(5): 1727 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Checchia, R. Larsen, R. Sehra, N. Daher, S. R. Gundry, A. J. Razzouk, and L. L. Bailey Effect of a selection and postoperative care protocol on survival of infants with hypoplastic left heart syndrome Ann. Thorac. Surg., February 1, 2004; 77(2): 477 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Karimi, L. X. Wang, J. M. Hammel, C. E. Mascio, M. Abdulhamid, E. W. Barner, T. D. Scholz, J. L. Segar, W. G. Li, S. D. Niles, et al. Neonatal vulnerability to ischemia and reperfusion: Cardioplegic arrest causes greater myocardial apoptosis in neonatal lambs than in mature lambs J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 490 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Schroeder, J. M. Pearl, S. M. Schwartz, T. P. Shanley, P. B. Manning, and D. P. Nelson Combined Steroid Treatment for Congenital Heart Surgery Improves Oxygen Delivery and Reduces Postbypass Inflammatory Mediator Expression Circulation, June 10, 2003; 107(22): 2823 - 2828. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |